ClinicalTrials.gg
CompletedNCT02386683Updated Aug 30, 2023

Intraoperative Lung-Protective Ventilation in Neurosurgery

An interventional study of lung-protective ventilation in Ventilator-induced Lung Injury, sponsored by Capital Medical University. Completed at 1 site in China. Open to participants aged 40 Years to 80 Years. Per ClinicalTrials.gov, last updated 2023-08-30.

Sponsored by Capital Medical University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
360
Allocation
Randomized
Ages
40 Years to 80 Years
Sex
All
01

Study summary

The purpose of this study is to explore the effectiveness of lung-protective ventilation during general anesthesia for neurosurgical procedures on postoperative pulmonary outcome, compared with traditional ventilation.

Read the detailed description

After screened for preoperative risk classification of postoperative respiratory complications,360 patients undergoing elective neurosurgery are randomly assigned to two groups, lung-protective ventilation (L) and traditional ventilation(T).Patients are mechanical ventilated with either a tidal volume of 10-12 ml/kg ideal body weight (IBW,T) or 6-8ml/kg IBW with 6-8 cm H2O PEEP(L),both with recruitment maneuver (RM).Each RM consists of applying a continuous positive airway pressure of 30 cmH2O for 30 seconds. Postoperative pulmonary complications are compared between groups.

02

Conditions studied

  • Ventilator-induced Lung Injury

Keywords

  • Protective mechanical ventilation
  • ventilator-induced lung injury
  • neurosurgery
03

In context

Ventilator-Induced Lung Injury

100 studies on the registry are indexed under Ventilator-Induced Lung Injury; 35 are open to participants now.

This study's enrollment of 360 is above the median of 38 across 60 interventional studies indexed under Ventilator-Induced Lung Injury.

Browse Ventilator-Induced Lung Injury studies →

Lead sponsor

Capital Medical University is the lead sponsor of 293 studies on the registry; 91 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. > 40 years ,and \< 80 years
  2. Scheduled for neurosurgery
  3. After informed consent has been obtained
  4. With an expected duration of ≥ 4 hours
  5. preoperative risk index for pulmonary complications≥ 2
  6. Glasgow Coma Scale >8

Exclusion criteria

Exclusion Criteria:

  1. Mechanical ventilation of > 1 hour within the last 2 weeks before surgery
  2. Body mass index ≥ 35 kg/m2
  3. Acute respiratory failure (pneumonia, acute lung injury or acute respiratory distress syndrome)
  4. Emergency surgery
  5. Severe cardiac disease
  6. Progressive neuromuscular illness
  7. Pregnancy
  8. Refusal to participate
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Investigator)
Enrollment
360 participants (actual)

Study arms

  • Active comparator
    Group L

    lung-protective ventilation applied in anesthesia

    Other: lung-protective ventilation

  • No intervention
    Group T

    traditional ventilation applied in anesthesia

Interventions

  • Otherlung-protective ventilation

    mechanical ventilated with a tidal volume of 6-8ml/kg ideal body weight (IBW) and 6-8 cm H2O PEEP in anesthesia

06

What researchers measure

Primary outcomes

  1. Postoperative pulmonary complications

    modified Clinical Pulmonary Infection Score (mCPIS):Temperature,Blood leukocytes,Tracheal secretions,Oxygenation Pao2/Fio2,Chest radiograph; Grade scale for postoperative pulmonary complications:Grade 0 representing the absence of any pulmonary complication and grades 1 through 4 representing successively the worse forms of complications

    Time frame: 7 days after surgery

Secondary outcomes

  1. Intraoperative brain relaxation.

    using a four-point scale: 1, completely relaxed; 2, satisfactorily relaxed; 3, firm brain; 4, bulging brain;

    Time frame: 1 day undergonging surgery

  2. The postoperative complications within 30 days

    Surgical complications,Systematic complications; Septic shock, Death

    Time frame: 30 days after surgery

  3. Postoperative hypoxemia

    PaO2 less than 60 mmHg, SpO2 less than 90%; PaO2 /FiO2 less than 300.

    Time frame: 7 days after surgery

  4. Peripheral blood inflammatory response indicators

    interleukin 6, tumor necrosis factor TNF-α.

    Time frame: 1 day after surgery

  5. Postoperative antibiotic usage

    antibiotic dose

    Time frame: 30 days after surgery

  6. Postoperative pulmonary complications

    modified Clinical Pulmonary Infection Score (mCPIS):Temperature,Blood leukocytes,Tracheal secretions,Oxygenation Pao2/Fio2,Chest radiograph; Grade scale for postoperative pulmonary complications:Grade 0 representing the absence of any pulmonary complication and grades 1 through 4 representing successively the worse forms of complications

    Time frame: 30 days after surgery

  7. Unanticipated ICU treatment.

    Unanticipated ICU treatment.

    Time frame: 30 days after surgery

  8. ICU stay and length of hospital stay

    ICU stay and length of hospital stay

    Time frame: 30 days after surgery

  9. All cause of mortality at 30 days

    mortality

    Time frame: 30 days after surgery

  10. Cost analysis

    Data of total non-operative costs, costs per day.

    Time frame: 30 days after surgery

07

Study locations

1 site
  • Department of Anesthesiology,Beijing Tiantan Hospital, Capital Medical University
    Beijing, Beijing Municipality 100050, China
08

References and documents

Publications

  • Zhang L, Xiong W, Peng Y, Zhang W, Han R. The effect of an intraoperative, lung-protective ventilation strategy in neurosurgical patients undergoing craniotomy: study protocol for a randomized controlled trial. Trials. 2018 Feb 2;19(1):85. doi: 10.1186/s13063-018-2447-4. PubMed 29394907 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Oct 2015 to primary completion in Mar 2020, 53 months.

Of 36 interventional studies with no phase under Ventilator-Induced Lung Injury, half reached primary completion within 32 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 54. This study's 53 months is above that.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 18, 2014
First posted
Mar 12, 2015
StartActual
Oct 2015
Primary completionActual
Mar 2020
CompletionActual
Nov 2020
Last update
Aug 30, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 30, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02386683
Responsible party
Wei Zhang (attending doctor, Capital Medical University) — Principal investigator
First posted
Mar 12, 2015
Start date
Oct 2015
Primary completion
Mar 2020
Completion
Nov 2020
Last update
Aug 30, 2023

Study contacts

Ruquan Han, MD
study chair · Department of Anesthesiology, Beijing Tiantan Hospital, Capital Medical University
liyong Zhang, MD
study director · Department of Anesthesiology, Beijing Tiantan Hospital, Capital Medical University

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion